NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, will showcase its versatile lung solution and its COMPASS® Hematopathology Services portfolio at the American Society of Clinical Oncology (ASCO) conference in Chicago, May 31–June 4 (booth #31093).
Jim Cramer Over The Moon About How Amazon’s Q3 ‘Came Together’ As He Praises ‘Unreal’ Earnings Call
Cramer raved over Amazon's quarterly results, especially the management commentary on the earnings call that hinted at strong AWS growth.
